Litigation Details for AbbVie Inc. v. Alembic Pharmaceuticals Ltd. (D. Del. 2020)
✉ Email this page to a colleague
AbbVie Inc. v. Alembic Pharmaceuticals Ltd. (D. Del. 2020)
Docket | ⤷ Sign Up | Date Filed | 2020-07-28 |
Court | District Court, D. Delaware | Date Terminated | |
Cause | 35:271 Patent Infringement | Assigned To | |
Jury Demand | None | Referred To | |
Patents | 8,722,657 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in AbbVie Inc. v. Alembic Pharmaceuticals Ltd.
Details for AbbVie Inc. v. Alembic Pharmaceuticals Ltd. (D. Del. 2020)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
0000-00-00 | External link to document | |||
2020-07-28 | 4 | Patent/Trademark Report to Commissioner of Patents | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,722,657. (nmg) (Entered: 07… 28 July 2020 1:20-cv-01009 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |